Literature DB >> 21148408

Calcium-induced permeability transition in rat brain mitochondria is promoted by carbenoxolone through targeting connexin43.

Tamara Azarashvili1, Yulia Baburina, Dmitry Grachev, Olga Krestinina, Yuri Evtodienko, Rolf Stricker, Georg Reiser.   

Abstract

Carbenoxolone (Cbx), a substance from medicinal licorice, is used for antiinflammatory treatments. We investigated the mechanism of action of Cbx on Ca(2+)-induced permeability transition pore (PTP) opening in synaptic and nonsynaptic rat brain mitochondria (RBM), as well as in rat liver mitochondria (RLM), in an attempt to identify the molecular target of Cbx in mitochondria. Exposure to threshold Ca(2+) load induced PTP opening, as seen by sudden Ca(2+) efflux from the mitochondrial matrix and membrane potential collapse. In synaptic RBM, Cbx (1 μM) facilitated the Ca(2+)-induced, cyclosporine A-sensitive PTP opening, while in nonsynaptic mitochondria the Cbx threshold concentration was higher. A well-known molecular target of Cbx is the connexin (Cx) family, gap junction proteins. Moreover, Cx43 was previously found in heart mitochondria and attributed to the preconditioning mechanism of protection. Thus, we hypothesized that Cx43 might be a target for Cbx in brain mitochondria. For the first time, we detected Cx43 by Western blot in RBM, but Cx43 was absent in RLM. Interestingly, two anti-Cx43 antibodies, directed against amino acids 252 to 270 of rat Cx43, abolished the Cbx-induced enhancement of PTP opening in total RBM and in synaptic mitochondria, but not in RLM. In total RBM and in synaptic mitochondria, PTP caused dephosphorylation of Cx43 at serine 368. The phosphorylation level of serine 368 was decreased at threshold calcium concentration and additionally in the combined presence of Cbx in synaptic mitochondria. In conclusion, active mitochondrial Cx43 appears to counteract the Ca(2+)-induced PTP opening and thus might inhibit the PTP-ensuing mitochondrial demise and cell death. Consequently, we suggest that activity of Cx43 in brain mitochondria represents a novel molecular target for protection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21148408     DOI: 10.1152/ajpcell.00061.2010

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  20 in total

1.  Connexin 30 expression inhibits growth of human malignant gliomas but protects them against radiation therapy.

Authors:  Maria Artesi; Jerome Kroonen; Markus Bredel; Minh Nguyen-Khac; Manuel Deprez; Laurent Schoysman; Christophe Poulet; Arnab Chakravarti; Hyunsoo Kim; Denise Scholtens; Tatjana Seute; Bernard Rogister; Vincent Bours; Pierre A Robe
Journal:  Neuro Oncol       Date:  2014-08-25       Impact factor: 12.300

2.  Subcellular preconditioning of stem cells: mito-Cx43 gene targeting is cytoprotective via shift of mitochondrial Bak and Bcl-xL balance.

Authors:  Gang Lu; Shujia Jiang; Muhammad Ashraf; Khawaja Husnain Haider
Journal:  Regen Med       Date:  2012-05       Impact factor: 3.806

3.  Chemical synapses without synaptic vesicles: Purinergic neurotransmission through a CALHM1 channel-mitochondrial signaling complex.

Authors:  Roman A Romanov; Robert S Lasher; Brigit High; Logan E Savidge; Adam Lawson; Olga A Rogachevskaja; Haitian Zhao; Vadim V Rogachevsky; Marina F Bystrova; Gleb D Churbanov; Igor Adameyko; Tibor Harkany; Ruibiao Yang; Grahame J Kidd; Philippe Marambaud; John C Kinnamon; Stanislav S Kolesnikov; Thomas E Finger
Journal:  Sci Signal       Date:  2018-05-08       Impact factor: 8.192

Review 4.  Supportive or detrimental roles of P2Y receptors in brain pathology?--The two faces of P2Y receptors in stroke and neurodegeneration detected in neural cell and in animal model studies.

Authors:  Daniel Förster; Georg Reiser
Journal:  Purinergic Signal       Date:  2015-09-25       Impact factor: 3.765

Review 5.  Gap junctions.

Authors:  Morten Schak Nielsen; Lene Nygaard Axelsen; Paul L Sorgen; Vandana Verma; Mario Delmar; Niels-Henrik Holstein-Rathlou
Journal:  Compr Physiol       Date:  2012-07       Impact factor: 9.090

Review 6.  Connexins in the Heart: Regulation, Function and Involvement in Cardiac Disease.

Authors:  Antonio Rodríguez-Sinovas; Jose Antonio Sánchez; Laura Valls-Lacalle; Marta Consegal; Ignacio Ferreira-González
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

Review 7.  Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection.

Authors:  Rainer Schulz; Philipp Maximilian Görge; Anikó Görbe; Péter Ferdinandy; Paul D Lampe; Luc Leybaert
Journal:  Pharmacol Ther       Date:  2015-06-11       Impact factor: 12.310

8.  Cardiomyocyte FGF signaling is required for Cx43 phosphorylation and cardiac gap junction maintenance.

Authors:  Takashi Sakurai; Mariko Tsuchida; Paul D Lampe; Masahiro Murakami
Journal:  Exp Cell Res       Date:  2013-06-04       Impact factor: 3.905

Review 9.  Neuroprotection against hypoxia/ischemia: δ-opioid receptor-mediated cellular/molecular events.

Authors:  Xiaozhou He; Harleen K Sandhu; Yilin Yang; Fei Hua; Nathalee Belser; Dong H Kim; Ying Xia
Journal:  Cell Mol Life Sci       Date:  2012-09-27       Impact factor: 9.261

10.  Carbenoxolone induces permeability transition pore opening in rat mitochondria via the translocator protein TSPO and connexin43.

Authors:  Tamara Azarashvili; Yulia Baburina; Dmitry Grachev; Olga Krestinina; Vassilios Papadopoulos; John J Lemasters; Irina Odinokova; Georg Reiser
Journal:  Arch Biochem Biophys       Date:  2014-07-01       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.